Oxyrane ^Company

Central nervous system diseases, enzyme replacement therapies, lysosomal storage diseases. Oxyrane develops enhanced enzyme replacement therapies (ERTs) for the treatment of lysosomal storage diseases, with a focus on the diseases of the central nervous system.